For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Product sourcing reference

Semax / Selank Blend

A combination reference pairing two regulatory peptides developed in Russia. Neither is approved in the U.S.; review the request accordingly.

Reference variants

Add Semax / Selank Blend to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 20mg (10/10)Vial · confirm physical formCAS Multi-component
    Quote requiredReference listed as discontinued. Historical reference $24.44/vial; not an offer.
    Ask for a quote
  • 10mg/10mgSpray bottleCAS 80714-61-0 / 129954-34-3
    $45.00/bottle$30.00/bottle at 50+ bottles of this item
    bottles

Review your order request · Compare the full catalog

Confirm the exact substance

Semax is an ACTH(4-10) analogue and Selank is a tuftsin analogue. The vial blend is listed as discontinued; the spray is a separate format.

What the review will ask

Record the intended use and route. Nootropic marketing does not establish a regulatory pathway for either component.

  • State the facility type, destination state and intended transaction. Do not send patient information.
  • Expect product- and lot-specific documentation to be requested before any material is accepted.
  • A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Why is the vial blend quote-only?

The reference source marks the vial format discontinued. The spray remains requestable for review, subject to confirmation.

Review two components and two formats

The reference distinguishes a quote-only vial blend from a requestable spray, not two verified equivalent products. FDA discusses Semax and selank acetate separately.

Documentation to request

Ask for each component's amount and identity, and the spray's bottle volume and actuation specification. Do not infer availability from the other format.

Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Non-clinical protocol review checklist. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements
Call Apply for Wholesale